Profile
Dr. Rebecca Pruss is Chief Scientific Officer at Trophos SA. Dr. Pruss was previously employed as Head-Exploratory Research by Sanofi-Synthelabo Canada, Inc.
Former positions of Rebecca Pruss
| Companies | Position | End |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Chief Tech/Sci/R&D Officer | 30/09/2015 |
| Sanofi-Synthelabo Canada, Inc. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
| Sanofi-Synthelabo Canada, Inc. |
- Stock Market
- Insiders
- Rebecca Pruss
